Suven Life Sciences Ltd 530239
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹141.75
- Day Range
- ₹139.85–147.05
- 52-Week Range
- ₹60.96–169.00
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹30.92 Bil
- Volume/Avg
- 10,272 / 65,319
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 346.73
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. The company's only segment is providing Research and Development services. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates for CNS disorders.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 141
- Website
- https://www.suven.com
Comparables
Valuation
|
Metric
|
530239
|
543322
|
STAR
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 31.41 | 188.30 |
Price/Book Value | 11.45 | 6.08 | 6.31 |
Price/Sales | 346.73 | 6.44 | 3.30 |
Price/Cash Flow | — | 25.87 | 27.25 |
Price/Earnings
530239
543322
STAR
Financial Strength
|
Metric
|
530239
|
543322
|
STAR
|
|---|---|---|---|
Quick Ratio | 7.11 | 2.64 | 0.55 |
Current Ratio | 18.99 | 4.37 | 1.03 |
Interest Coverage | −969.48 | 391.89 | 0.78 |
Quick Ratio
530239
543322
STAR
Profitability
|
Metric
|
530239
|
543322
|
STAR
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
530239
543322
STAR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Bhqzkxgfz | Xxlw | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Czzvnhws | Cdztb | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Yhzxccr | Vvtc | $45.9 Bil | |||
| Viatris Inc
VTRS
| Sjjdmwwz | Dvgys | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Vxqbbvpz | Nnnrj | $13.2 Bil | |||
| Catalent Inc
CTLT
| Psglbxwbv | Zdnkgq | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Mccjzxmpr | Qzhjst | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Ydkytdds | Hjfg | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Whmljfdf | Kgm | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Xrznnlggv | Jsfx | $2.2 Bil |
United States